Medical technology company eNeura Inc. announced on Friday that it has secured the inclusion of its SAVI Dual sTMS Neuromodulation treatment in Recon Supply's Federal Supply Schedule (FSS) contract.

This move enhances access to non-invasive migraine therapy for veterans, active-duty military and other federal healthcare beneficiaries. The FDA-cleared SAVI Dual sTMS offers a portable, patient-controlled, medication-free alternative for acute migraines and prevention.

Key federal agencies, including the Department of Veterans Affairs, Department of Defense and Indian Health Services, can now procure the treatment at negotiated pricing. Streamlined access to this innovative solution supports efforts to address migraines among millions of Americans, including military personnel and veterans. This milestone underscores eNeura Inc.'s commitment to advancing migraine care.